00
Days
:
00
Hours
:
00
Minutes
17th Annual Global Patient Insights & Engagement
Summit
24 – 25 September, 2025
Berlin
Past Speakers
SEE THE PREVIOUS SPEAKERS & CASE STUDIES
CASE STUDY
Safety Reimagined: Cultivating a Culture of Care
The credit card industry has undergone significant changes over the years, driven by technological advancements, changing consumer behaviours, and regulatory developments. This presentation will trace the evolution of credit card product management, from its early days to the present, and explore the key trends shaping its future. We will discuss how product managers have adapted to new challenges and opportunities, such as the rise of digital payments, the importance of data analytics, and the increasing focus on sustainability. We will also examine the role of innovation in driving product development and enhancing the customer experience. Finally, we will look ahead to the future of credit card product management, discussing emerging trends and strategies that will shape the industry in the years to come.
Cultivating a safety culture: Importance of leadership commitment, employee training, and open communication. How these practices contribute to reducing errors and enhancing patient outcomes?
- 01Understanding the current landscape of the aesthetics dermatology industry
- 02Analysing key market trends shaping the future of aesthetic solutions
- 03Strategies for seizing opportunities and staying ahead of competitors
- 04Leveraging innovation to drive growth and success in aesthetics
- 05A case study showcasing successful market leadership in the industry
CASE STUDY
A Snapshot of Latest Clinical Trends: Patient-Centred Outcomes
Since the invention of Bitcoin, digital money and assets have taken the banking industry by storm. JP Morgan is operating a dollar-backed stablecoin with 1bm USD in daily volumes and a smart contracts platform offering instant transfers and settlement of financial assets. At the same time, BCG estimates that asset tokenisation will reach 16 trillion dollars by 2030. Banks have already passed Proof of Concept and are coming out with their first marketable products. Taking action is becoming imperative for banks to remain competitive.
The role of the patient in clinical trials is shifting from a mere traditional patient to a partner in clinical research development. The presentation will focus on patient-focused drug development by providing an overview of what it means and how this area is projected to continue to grow significantly.
- 01Provide an overview of what patient-centred outcomes within the context of clinical research
- 02Discuss the shift to prioritising patient outcomes like daily functioning, health-related quality of life, and beyond
- 03Describe the route of traditional versus latest digital clinical outcome assessments (COAs)
- 04Explore why it is important to hear the patient’s voice in clinical research
CASE STUDY
Purpose - the fuel for success
Travelling through a real case example, we will understand how machine learning can drive us to the most effective engagement model, deployment and resource optimisation. We will also cover the hurdles of implementing this model, the change in culture and mindset required, and how to move to liquid organisations with success.
In this session, we delve into the transformative world of omnichannel communication within global and local medical affairs. We will explore strategies and requirements for implementing an omnichannel approach, ensuring healthcare professionals have seamless access to diverse resources across multiple platforms. The session will highlight how leveraging data can refine and personalise communication methods, thus enhancing their impact on the target audience. Additionally, the presentation will address the importance of facilitating effective cross-functional communication among medical and commercial teams, especially in fostering a unified strategy. Finally, we will explore methods to tailor content and messaging to suit the diverse preferences of different healthcare professionals and stakeholders. This session promises to offer valuable insights and practical tools for anyone looking to enhance their communication strategies in the rapidly evolving healthcare sector.
- 01Machine learning
- 02Sensitiveness of promotion: Productive frequencies/actions
- 03Optimisation of deployment
- 04Maximisation of field investment
- 05Liquid structures in the field
- 06Data culture in SFE decisions
CASE STUDY
Transforming Clinical Trials With Patient Feedback
I will present data on the rising burden of participation in clinical trials, try to give an overview of possibilities of patient feedback collecting methods, including patient preference studies, patient focus groups and advisory boards, and present examples of how these different approaches may reshape the design, execution and outcome of clinical trials to meet better patient needs and preferences.
- 01The participation burden for patients in clinical trials is rising
- 02What methods are being used to collect and incorporate patient input in clinical trial protocols?
- 03How may the integration of patient feedback reshape the design, execution and outcome of clinical trials?
In this session, we delve into the transformative world of omnichannel communication within global and local medical affairs. We will explore strategies and requirements for implementing an omnichannel approach, ensuring healthcare professionals have seamless access to diverse resources across multiple platforms. The session will highlight how leveraging data can refine and personalise communication methods, thus enhancing their impact on the target audience. Additionally, the presentation will address the importance of facilitating effective cross-functional communication among medical and commercial teams, especially in fostering a unified strategy. Finally, we will explore methods to tailor content and messaging to suit the diverse preferences of different healthcare professionals and stakeholders. This session promises to offer valuable insights and practical tools for anyone looking to enhance their communication strategies in the rapidly evolving healthcare sector.
CASE STUDY
The Next Stage of Patient Affairs in Pharmaceutical Industry
New technologies are rapidly changing the way we think about medicine development. The advances in Artificial Intelligence and digital enablers will boost our understanding of disease biologies, fundamentally change evidence generation and impact healthcare decisions. With patient engagement and the use of patient experience data still in its “teenage years” — how can we work together towards rapid adaption in a timely way?
- 01Some main opportunities and challenges from the tech evolution in relation to patient engagement
- 02Can we already see signs of the future — e. g., in relation to how we collect patient experience data
- 03How can the industry and the patient community collaborate to prepare for the future?
Welcome to “Charting the Course: Our Influence on the HCP/Customer Engagement Trek”. Today, we embark on a journey to explore our impact on the ever-evolving landscape of healthcare professional (HCP) and customer engagement. In a world shaped by technology, ethics, and personalisation, our role as navigators of this journey is pivotal. Throughout this discourse, we’ll delve into key topics that define our approach, from leveraging technology to building meaningful connections. Join me as we navigate through these waters together, shaping not just outcomes, but the very fabric of trust and collaboration that underpins every meaningful engagement.
CASE STUDY
Safety Reimagined: Cultivating a Culture of Care
The credit card industry has undergone significant changes over the years, driven by technological advancements, changing consumer behaviours, and regulatory developments. This presentation will trace the evolution of credit card product management, from its early days to the present, and explore the key trends shaping its future. We will discuss how product managers have adapted to new challenges and opportunities, such as the rise of digital payments, the importance of data analytics, and the increasing focus on sustainability. We will also examine the role of innovation in driving product development and enhancing the customer experience. Finally, we will look ahead to the future of credit card product management, discussing emerging trends and strategies that will shape the industry in the years to come.
Cultivating a safety culture: Importance of leadership commitment, employee training, and open communication. How these practices contribute to reducing errors and enhancing patient outcomes?
- 01Understanding the current landscape of the aesthetics dermatology industry
- 02Analysing key market trends shaping the future of aesthetic solutions
- 03Strategies for seizing opportunities and staying ahead of competitors
- 04Leveraging innovation to drive growth and success in aesthetics
- 05A case study showcasing successful market leadership in the industry
CASE STUDY
A Snapshot of Latest Clinical Trends: Patient-Centred Outcomes
Since the invention of Bitcoin, digital money and assets have taken the banking industry by storm. JP Morgan is operating a dollar-backed stablecoin with 1bm USD in daily volumes and a smart contracts platform offering instant transfers and settlement of financial assets. At the same time, BCG estimates that asset tokenisation will reach 16 trillion dollars by 2030. Banks have already passed Proof of Concept and are coming out with their first marketable products. Taking action is becoming imperative for banks to remain competitive.
The role of the patient in clinical trials is shifting from a mere traditional patient to a partner in clinical research development. The presentation will focus on patient-focused drug development by providing an overview of what it means and how this area is projected to continue to grow significantly.
- 01Provide an overview of what patient-centred outcomes within the context of clinical research
- 02Discuss the shift to prioritising patient outcomes like daily functioning, health-related quality of life, and beyond
- 03Describe the route of traditional versus latest digital clinical outcome assessments (COAs)
- 04Explore why it is important to hear the patient’s voice in clinical research
CASE STUDY
Purpose - the fuel for success
Travelling through a real case example, we will understand how machine learning can drive us to the most effective engagement model, deployment and resource optimisation. We will also cover the hurdles of implementing this model, the change in culture and mindset required, and how to move to liquid organisations with success.
In this session, we delve into the transformative world of omnichannel communication within global and local medical affairs. We will explore strategies and requirements for implementing an omnichannel approach, ensuring healthcare professionals have seamless access to diverse resources across multiple platforms. The session will highlight how leveraging data can refine and personalise communication methods, thus enhancing their impact on the target audience. Additionally, the presentation will address the importance of facilitating effective cross-functional communication among medical and commercial teams, especially in fostering a unified strategy. Finally, we will explore methods to tailor content and messaging to suit the diverse preferences of different healthcare professionals and stakeholders. This session promises to offer valuable insights and practical tools for anyone looking to enhance their communication strategies in the rapidly evolving healthcare sector.
- 01Machine learning
- 02Sensitiveness of promotion: Productive frequencies/actions
- 03Optimisation of deployment
- 04Maximisation of field investment
- 05Liquid structures in the field
- 06Data culture in SFE decisions
CASE STUDY
Transforming Clinical Trials With Patient Feedback
I will present data on the rising burden of participation in clinical trials, try to give an overview of possibilities of patient feedback collecting methods, including patient preference studies, patient focus groups and advisory boards, and present examples of how these different approaches may reshape the design, execution and outcome of clinical trials to meet better patient needs and preferences.
- 01The participation burden for patients in clinical trials is rising
- 02What methods are being used to collect and incorporate patient input in clinical trial protocols?
- 03How may the integration of patient feedback reshape the design, execution and outcome of clinical trials?
In this session, we delve into the transformative world of omnichannel communication within global and local medical affairs. We will explore strategies and requirements for implementing an omnichannel approach, ensuring healthcare professionals have seamless access to diverse resources across multiple platforms. The session will highlight how leveraging data can refine and personalise communication methods, thus enhancing their impact on the target audience. Additionally, the presentation will address the importance of facilitating effective cross-functional communication among medical and commercial teams, especially in fostering a unified strategy. Finally, we will explore methods to tailor content and messaging to suit the diverse preferences of different healthcare professionals and stakeholders. This session promises to offer valuable insights and practical tools for anyone looking to enhance their communication strategies in the rapidly evolving healthcare sector.
CASE STUDY
The Next Stage of Patient Affairs in Pharmaceutical Industry
New technologies are rapidly changing the way we think about medicine development. The advances in Artificial Intelligence and digital enablers will boost our understanding of disease biologies, fundamentally change evidence generation and impact healthcare decisions. With patient engagement and the use of patient experience data still in its “teenage years” — how can we work together towards rapid adaption in a timely way?
- 01Some main opportunities and challenges from the tech evolution in relation to patient engagement
- 02Can we already see signs of the future — e. g., in relation to how we collect patient experience data
- 03How can the industry and the patient community collaborate to prepare for the future?
Welcome to “Charting the Course: Our Influence on the HCP/Customer Engagement Trek”. Today, we embark on a journey to explore our impact on the ever-evolving landscape of healthcare professional (HCP) and customer engagement. In a world shaped by technology, ethics, and personalisation, our role as navigators of this journey is pivotal. Throughout this discourse, we’ll delve into key topics that define our approach, from leveraging technology to building meaningful connections. Join me as we navigate through these waters together, shaping not just outcomes, but the very fabric of trust and collaboration that underpins every meaningful engagement.
Hottest topics
LOOK AT THE TOPICS THAT WERE DISCUSSED
- 01How Do Evolving Patient Expectations and the Increasing Demand for Personalised Care Influence the Future Direction of Patient Affairs?
- 02Patient-Centric Trial Design: Trends and Innovations
- 03How Can Researchers Effectively Address Patient Concerns and Anxieties About Participation to Enhance Retention?
- 04The Age of Personalisation: Tailoring Advocacy Efforts to Meet the Unique Needs of Diverse Patient Populations
- 05Innovative Strategies for Engaging Patients Through Digital Platforms and Virtual Health Initiatives
- 06Game Changer: How RWE is Shaking Up Patient Recruitment and Engagement?
Testimonials
What our users say about our conferences
I really liked the atmosphere, interactive sessions, networking, professionalism and the quality of speakers.
The Janssen Pharmaceutical Companies of Johnson & Johnson
Director, Patient Engagement Strategy
Great opportunities to share best practices.
Novartis
Patient Engagement Head in France
I like that it was a small group. Excellent networking.
Roche
Global Patient Partnership Director
Excellent conference. Great discussions. The size of this conference allows for great dialogues.
Ipsen
Global Patient Centricity Director
Sponsors
Past Sponsors at This Summit
Download our App to
Enhance Your Event Experience
This innovative app is aimed at enhancing your networking experience through a seamless blend of interaction and connectivity. We have carefully crafted this application with new features that empower you to make the most out of your engagements, ensuring personalised experiences and seamless networking opportunities.
STAY UPDATED FOR THE 2026 EDITION
Provide Us With Your Contact Details and Our Team Will Get Back to You
With All the Updates Regarding the Upcoming Edition of This Event.
With All the Updates Regarding the Upcoming Edition of This Event.